FENC - NASDAQ

Fennec Pharmaceuticals Inc.

FENC·NASDAQ

$9.98

-8.4%

HealthcareBiotechnology

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$285.23M

EPS-0.3600

P/E Ratio-22.59

Earnings Date08/13/2026

fenc

Revenue

Last Annual Value

44.64M

3-Year CAGR

212%

5-Year CAGR

205%

10-Year CAGR

Adjust for Inflation

Fennec Pharmaceuticals Inc. Competitors Analysis of Revenue

FENC · NASDAQ

Company	Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
Fennec Pharmaceuticals Inc. NASDAQ:FENC	44.64M	28.1%	N/A	N/A
Orchestra BioMed Holdings, Inc. NASDAQ:OBIO	33.48M	129.8%	N/A	N/A
Black Diamond Therapeutics, Inc. NASDAQ:BDTX	70.00M	N/A	N/A	N/A
Assembly Biosciences, Inc. NASDAQ:ASMB	72.30M	116.1%	63.2%	N/A
Immuneering Corporation NASDAQ:IMRX	0.00	N/A	N/A	N/A
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	0.00	N/A	N/A	N/A
Sagimet Biosciences Inc. NASDAQ:SGMT	0.00	N/A	N/A	N/A
Entrada Therapeutics, Inc. NASDAQ:TRDA	25.42M	-41.8%	N/A	N/A
Zura Bio Limited NASDAQ:ZURA	0.00	N/A	N/A	N/A
Caribou Biosciences, Inc. NASDAQ:CRBU	11.16M	-31.3%	3.1%	N/A
Cartesian Therapeutics, Inc. NASDAQ:RNAC	2.80M	-52.4%	-49.5%	-10.1%

Fennec Pharmaceuticals Inc. Fair Value Envelope

FENC · NASDAQ

Our analysis suggests that FENC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.98, this represents a potential HIDDEN relative to our calculated worth for Fennec Pharmaceuticals Inc..

HIDDEN

Intrinsic Value

Current Price: $9.98

Related Guides

Blog Categories

Continue your FENC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.